← Back to Bills
SRES 775118th CongressFailed / ExpiredSenate

A resolution expressing support for the designation of July 15, 2024, as "National Leiomyosarcoma Awareness Day".

Policy Area: Health
View on Congress.gov
Origin Chamber
Senate
Last Updated
Apr 21, 2025
Latest Action Date
Jul 30, 2024

Latest Action

Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S5587-5588)

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

Senate Resolution 775 from the 118th Congress is a non-binding resolution expressing support for designating July 15, 2024, as "National Leiomyosarcoma Awareness Day." The resolution aims to raise public awareness about leiomyosarcoma, a rare type of cancer. The bill was referred to the Senate Committee on Health, Education, Labor, and Pensions but ultimately failed or expired without further action. The resolution does not include legislative provisions, funding, or regulatory changes.

Bottom Line

S.Res. 775 sought to officially recognize a day to raise awareness about leiomyosarcoma but did not advance beyond committee referral and expired without enactment.

Policy Risk Level
🟢 Low
Neutral Risk Assessment
Key Points
  • The resolution designates July 15, 2024, as National Leiomyosarcoma Awareness Day.
  • It is a non-binding expression of support without legislative or funding authority.
  • The resolution was referred to the Senate Committee on Health, Education, Labor, and Pensions but did not progress further.
Who Benefits?

['Individuals affected by leiomyosarcoma and their families', 'Health advocacy groups focused on rare cancers', 'Medical and research communities interested in leiomyosarcoma']

Potential Concerns

['No direct implementation or funding mechanisms are included, limiting practical impact.', 'As a non-binding resolution, it carries no enforcement authority or policy changes.', "The resolution's failure to advance may reflect competing legislative priorities."]

Political Context

The resolution was introduced in the Senate during the 118th Congress and referred to the relevant health committee. It aligns with broader efforts to recognize and raise awareness of rare diseases but did not receive further legislative action before expiring.

Hidden Impact Review

No hidden impact flags detected

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

Clear Review
Categories Reviewed — Not Detected
Funding or Enforcement Authority
Broad Policy Impact
Indirect Effects

['Increased public awareness of leiomyosarcoma could potentially lead to greater advocacy and funding for research in the future.', 'Recognition of a national awareness day may encourage healthcare providers to improve education and outreach related to this rare cancer.']

GovScope Watchdog Notes

As a non-binding resolution without legislative or funding provisions, this bill primarily serves a symbolic purpose. Transparency considerations include the lack of detailed legislative text and the absence of subsequent committee or floor actions. Monitoring similar resolutions can help assess trends in congressional recognition of health issues.

Passage Likelihood: LowConfidence: 90%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready